Canada: Getting Behind COVID-19 Vaccine Innovators - Part III – There Is Much New Supply From Innovators That Is Not Being Equitably Distributed - Bereskin & Parr LLP

Canada: Getting Behind COVID-19 Vaccine Innovators - Part III – There Is Much New Supply From Innovators That Is Not Being Equitably Distributed - Bereskin & Parr LLP

Mondaq

Published

This final installment of the article addresses what needs to be done after there has been rapid output of safe innovator vaccines (see Part I for scaling and Part II for safety).

Full Article